Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies

Journal of Urology

Volumn 190, Issue 1, 2013, Pages 199-207

  Gelbard, Martin ^a,b   Goldstein, Irwin ^c,d   Hellstrom, Wayne J G ^e   McMahon, Chris G ^f,g   Smith, Ted ^h   Tursi, James ^h   Jones, Nigel ⁱ   Kaufman, Gregory J ^h   Carson III, Culley C ^j  

^a Urology Associates Medical Group   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c San Diego Sexual Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF SYDNEY   (Australia)

^g Australian Centre for Sexual Health   (Australia)

^h Auxilium Pharmaceuticals Inc   (United States)

ⁱ Auxilium Pharmaceuticals Inc   (United Kingdom)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

clinical trials as topic; microbial collagenase; penile induration; placebos; randomized controlled trials as topic

Indexed keywords

CLOSTRIDIOPEPTIDASE A; DRUG ANTIBODY;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEMATOMA; HUMAN; META ANALYSIS; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; PENILE SWELLING; PENIS DISEASE; PENIS ECCHYMOSIS; PENIS HEMATOMA; PENIS INJURY; PENIS PAIN; PEYRONIE DISEASE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; CLINICAL TRIALS, PHASE III AS TOPIC; CLOSTRIDIUM HISTOLYTICUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MAXIMUM TOLERATED DOSE; MICROBIAL COLLAGENASE; MIDDLE AGED; PATIENT SAFETY; PATIENT SATISFACTION; PENILE INDURATION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84878842586     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.01.087     Document Type: Article

References (20)

1. F.L. Taylor, L.A. Levine Peyronie's disease Urol Clin North Am 34 2007 517
2. R. Rosen, J. Catania, T. Lue Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls J Sex Med 5 2008 1977
3. J.F. Smith, T.J. Walsh, S.L. Conti Risk factors for emotional and relationship problems in Peyronie's disease J Sex Med 5 2008 2179
4. C.J. Nelson, C. Diblasio, M. Kendirci The chronology of depression and distress in men with Peyronie's disease J Sex Med 5 2008 1985
5. F.L. Taylor, L.A. Levine Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow up J Sex Med 5 2008 2221
6. E. Chung, E. Clendinning, L. Lessard Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction J Sex Med 8 2010 594
7. J.S. Benson, M.R. Abern, L.A. Levine Penile shortening after radical prostatectomy and Peyronie's surgery Curr Urol Rep 10 2009 468
8. A. Muller, J.P. Mulhall Peyronie's disease intervention trials: methodological challenges and issues J Sex Med 6 2009 848
9. D. Ralph, N. Gonzalez-Cadavid, V. Mirone The management of Peyronie's disease: evidence-based 2010 guidelines J Sex Med 7 2010 2359
10. S. Russell, W. Steers, K.T. McVary Systematic evidence-based analysis of plaque injection therapy for Peyronie's disease Eur Urol 51 2007 640
11. M.K. Gelbard, K. James, P. Riach Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study J Urol 149 1993 56
12. M.K. Gelbard, R. Walsh, J.J. Kaufman Collagenase for Peyronie's disease experimental studies Urol Res 10 1982 135
13. G.H. Jordan The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study J Sex Med 5 2008 180
14. M.K. Gelbard, A. Lindner, J.J. Kaufman The use of collagenase in the treatment of Peyronie's disease J Urol 134 1985 280
15. M.F. French, K.A. Mookhtiar, H.E. Van Wart Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns Biochemistry 26 1987 681
16. L.C. Hurst, M.A. Badalamente, V.R. Hentz Injectable collagenase clostridium histolyticum for Dupuytren's contracture N Engl J Med 361 2009 968
17. D. Gilpin, S. Coleman, S. Hall Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease J Hand Surg Am 35 2010 2027
18. M. Gelbard, L.I. Lipshultz, J. Tursi Phase 2b study of clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie's disease J Urol 187 2012 2268
19. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800
20. A. Dmitrienko, G. Molenberghs, C. Chuang-Stein Multiple comparisons and multiple endpoints Analysis of Clinical Trials Using SAS®: A Practical Guide 2005 SAS Institute Cary, North Carolina 67 127